Facial Wrinkles (Nasolabial Folds) Clinical Trial
Official title:
A Prospective, Multicentric, Open Label, Bio-Interventional, Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment of Facial Wrinkles (Nasolabial Folds)
Verified date | July 2012 |
Source | Kasiak Research Pvt. Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | India: Institutional Review Board |
Study type | Interventional |
This is a multicentre, open label, pilot study to evaluate safety and efficacy of Autologous Human Platelet Lysate (HPL) in subjects with Facial Wrinkles (Nasolabial Folds). The study is being conducted at 2 centers in India. The primary endpoints are Improvement in Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest and on full smile and Global Aesthetic Improvement Scale (GAIS). The secondary endpoints are improvement in photographic assessment, Physician's assessment scores, Patient's assessment scores form enrollment to end of study.
Status | Active, not recruiting |
Enrollment | 20 |
Est. completion date | November 2012 |
Est. primary completion date | October 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Subjects (male and female), aged 18 to 40 years (both inclusive). - Subjects willing to refrain from any other treatment for Nasolabial Folds. - Subjects who are willing to give informed consent and adhere to the study protocol. Exclusion Criteria: - Subjects receiving any aesthetic facial therapy 6 months prior to enrolment e.g. Botox, Fillers etc - Subjects with history of Connective tissue disease - Subjects with autoimmune diseases - Subjects unwilling to or unable to comply with the study protocol. - Subjects taking concomitant therapy that might interfere with the study results in the investigator's opinion or participating in another trial in the past 30days |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
India | Kasiak Research Pvt Ltd | Thane | Maharashtra |
Lead Sponsor | Collaborator |
---|---|
Kasiak Research Pvt. Ltd. |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Photographic assessments | Day 0, Month 1, Month 2, End of study - Month 3 | No | |
Other | Physician's assessment scores | End of Study - 3 months | No | |
Other | Patient's assessment scores | End of Study - 3 months | No | |
Primary | Wrinkle Severity Rating Scale as per ATLAS photographic grading at rest & on full smile | Day 0, End of Study - 3 months | No | |
Secondary | Global Aesthetic Improvement Scale | Day 0, End of study - Month 3 | No |